会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 43. 发明公开
    • 통증의 치료 또는 예방용 약학 조성물
    • 用于预防和治疗疼痛的药物组合物
    • KR1020100053027A
    • 2010-05-20
    • KR1020080111976
    • 2008-11-12
    • 주식회사 지엔티파마
    • 김기원권영배정낙신곽병주이영애
    • A61K31/075A61P23/00
    • PURPOSE: A composition containing an effective compound for pain for preventing neuropathic and inflammatory pain based on sigma 1 receptor suppression is provided. CONSTITUTION: A pharmaceutical composition contains a compound of chemical formula 1 or pharmaceutically acceptable salt thereof. In chemical formula 1, R1 is hydrogen or straight chain or side chain alkyl of C1-C6, and side chain alkyl, or cycloalkyl; R2 and R3 is straight chain or side chain alkyl of C1-C3; and R4 is straight chain or side chain linker containing C1-C4 alkyl or OH. The treatment or prevention for neuropathic or inflammatory pain is performed by administering a compound of chemical formula 1 or 2 or pharmaceutically acceptable salt.
    • 目的:提供一种含有基于西格玛1受体抑制的用于预防神经性和炎性疼痛的疼痛的有效化合物的组合物。 构成:药物组合物含有化学式1的化合物或其药学上可接受的盐。 在化学式1中,R 1是氢或C1-C6的直链或侧链烷基,和侧链烷基或环烷基; R2和R3是C1-C3的直链或侧链烷基; 并且R 4是含有C 1 -C 4烷基或OH的直链或侧链接头。 神经性或炎性疼痛的治疗或预防是通过施用化学式1或化合物2或其药学上可接受的盐来进行的。
    • 45. 发明公开
    • 염증질환 치료제
    • 治疗炎症性疾病
    • KR1020090128229A
    • 2009-12-15
    • KR1020080054293
    • 2008-06-10
    • 서울대학교산학협력단
    • 정지형유은숙당테흥강헌중
    • A61K31/201A61K31/075A61P29/00
    • PURPOSE: A therapeutic agent containing a compound as an active ingredient for treating inflammatory disease is provided to suppress generation of inflammatory media such as NO(nitrogen oxide), IL-6(interleukin-6) and TNF-α(tumor necrosis factor-alpha) in LPS-activated RAW 264.7 cell. CONSTITUTION: A therapeutic agent for treating inflammatory diseases contains a compound of the chemical formula 1 as an active ingredient. In chemical formula 1, R is COOH, COOCH3, CH2OH or CH2NHCOCF3, R1 and R2 is H, C6H5, or Br, and m is 1-5 integer and n is 1-4 integer. The compound of chemical formula 1 is (E)-11-oxooctadeca-9-enole, (E)-10- oxooctadeca-8-enole, (E)-9-oxooctadeca-10-enole or (E)-8-oxooctadeca-9-enole. The inflammatory diseases are rheumatoid arthritis, inflammatory bowel disease, osteoporosis, psoriasis, or toxic shock syndrome.
    • 目的:提供含有化合物作为治疗炎性疾病的活性成分的治疗剂,以抑制炎症介质如NO(氮氧化物),IL-6(白细胞介素-6)和TNF-α(肿瘤坏死因子-α )在LPS激活的RAW 264.7细胞中。 构成:用于治疗炎性疾病的治疗剂含有化学式1的化合物作为活性成分。 在化学式1中,R为COOH,COOCH3,CH2OH或CH2NHCOCF3,R1和R2为H,C6H5或Br,m为1-5整数,n为1-4整数。 化学式1的化合物是(E)-11-氧代十八碳-9-烯醇,(E)-10-氧代十八碳-8-烯醇,(E)-9-氧代十八碳-10-烯醇或(E)-8-氧代十八碳烯 -9- enole。 炎症性疾病是类风湿性关节炎,炎性肠病,骨质疏松症,牛皮癣或中毒性休克综合征。